Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Neutral

Analyst Rating

Neutral

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

NeuBase Therapeutics, Inc. Common Stock (NBSE)

Pharmaceutical Preparations

https://www.neubasetherapeutics.com

NeuBase Therapeutics Inc is a pre-clinical stage biopharmaceutical company. It is engaged in the development of gene silencing therapies with its synthetic antisense oligonucleotides. Its Patrol platform is focused on the development of drugs for rare genetic diseases such as Huntington's Disease, Myotonic Dystrophy and Familial Parkinson's Disease among others.

350 TECHNOLOGY DRIVE
PITTSBURGH, PA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/01/2007

Market Cap

1,418,101

Shares Outstanding

3,730,000

Weighted SO

3,729,206

Total Employees

N/A

Upcoming Earnings

02/13/2024

Similar Tickers

IMMX --.--%

CNSP --.--%

EFTR --.--%

NAVB --.--%

SONN --.--%

KRBP --.--%

ZVSA --.--%

YS --.--%

Beta

0.9450

Last Div

0.0000

Range

0.36-4.44

Chg

-0.0060

Avg Vol

128236

Mkt Cap

1418101

Exch

NASDAQ

Country

US

Phone

646 450 1790

DCF Diff

-9.5597

DCF

10.6297

Div Yield

0.0000

P/S

0.0000

EV Multiple

0.3994

P/FV

0.1141

Div Yield %

0.0000

P/E

-0.0728

PEG

0.0060

Payout

0.0000

Current Ratio

2.8713

Quick Ratio

2.7032

Cash Ratio

2.7032

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

110.4548

CCC

0.0000

Gross Margin

0.0000

Op Margin

0.0000

Pretax Margin

0.0000

Net Margin

0.0000

Eff Tax Rate

0.0707

ROA

-0.7687

ROE

-1.0792

ROCE

-1.0927

NI/EBT

1.0425

EBT/EBIT

0.8994

EBIT/Rev

0.0000

Debt Ratio

0.2865

D/E

0.5839

LT Debt/Cap

0.3460

Total Debt/Cap

0.3687

Int Coverage

-3160.5961

CF/Debt

-2.7707

Equity Multi

2.0381

Rec Turnover

0.0000

Pay Turnover

3.3045

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0000

OCF/Share

-5.3605

FCF/Share

-5.3835

Cash/Share

4.5585

OCF/Sales

0.0000

FCF/OCF

1.0043

CF Coverage

-2.7707

ST Coverage

-29.5159

CapEx Coverage

-233.5322

Div&CapEx Cov

-233.5322

P/BV

0.1141

P/B

0.1141

P/S

0.0000

P/E

-0.0728

P/FCF

-0.0955

P/OCF

-0.0705

P/CF

-0.0705

PEG

0.0060

P/S

0.0000

EV Multiple

0.3994

P/FV

0.1141

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation